NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHGRI E-007-1999-1-US-06 Cellular Arrays for Rapid Molecular Profiling US National Stage 09/622,635 Abandoned
NCI E-144-2000-0-US-01 GDEP, A Gene Highly Expressed In Normal And Neoplastic Prostate, And Uses Therefor US 60/239,413 Abandoned
NIMH E-178-1996-7-US-01 DELETION OF LYSOGENY GENES AND TOXIN GENES FROM BACTERIOPHAGE USED IN THE EPIDEMIOLOGIC CONTROL OF BACTERIAL ILLNESS US 60/238,425 Abandoned
NIMH E-178-1996-8-US-01 Therapeutic Use of Phage Expressing Toxin-Binding and/or Cytokine- Binding Proteins US 60/238,426 Abandoned
NCI E-090-2001-0-JP-10 Retroviral Protease Inhibiting Compound and Methods of Preparation, Pharmaceutical Compositions and Methods of Treating Viral Infections JP National Stage 2001-528184 Expired
NCI E-090-2001-0-AU-13 Hexahydrofuro'2,3-b!furan-3-yl-n- (3'(1,3-benzodioxol -5- ylsulfonyl) (isobutyl)amino -1-benzyl-2-hydroxypropyl) carbamate as retroviral protease inhibitor AU National Stage 2000/076638 Expired
NCI E-090-2001-0-PCT-02 Retroviral Protease Inhibiting Compound and Methods of Preparation, Pharmaceutical Compositions and Methods of Treating Viral Infections PCT PCT PCT/EP2000/009917 Expired
NCI E-090-2001-0-CZ-12 Retroviral Protease Inhibiting Compound and Methods of Preparation, Pharmaceutical Compositions and Methods of Treating Viral Infections CZ National Stage CZ 2002-1419 Expired
NCI E-090-2001-0-CN-06 Retroviral Protease Inhibiting Compound and Methods of Preparation, Pharmaceutical Compositions and Methods of Treating Viral Infections CN National Stage 00816587.4 Expired
NCI E-090-2001-0-KR-09 [1] HEXAHYDROFURO 2,3-BIFURAN-3-YL-N- {3(1,3-BENZODIOXOL-5-YLSULFONYL) (ISOBUTYL) AMINO -1-BENZYL-2-HYDROXYPROPY} -CARBAMATE AS RETROVIRAL PROTEASE KR National Stage 10-2002-7004284 Expired
NICHD E-309-2000-0-US-01 Probe Using Diffuse-Reflectance Spectroscopy US 60/238,600 Abandoned
CC E-319-2000-0-US-01 Plasmid Based Assay for the in vitro Repair of Oxidatively Induced DNA Double Strand Breaks US 60/238,757 Abandoned
NCI E-002-1996-1-US-15 MESOTHELIN, A DIFFERENTIATION ANTIGEN PRESENT ON MESOTHELIUM, MESOTHELIOMAS AND OVARIAN CANCERS AND METHODS AND KITS FOR TARGETING.. US DIV 09/684,599 7375183 Expired PDF
NIMH E-281-1999-0-PCT-02 Tyrosine-DNA Phosphodiestrerases(TDP) and Related Polypeptides, Nucleic Acids, Vectors, TDP-Producing Host Cells, Antibodies... PCT PCT PCT/US00/27400 Expired
NIEHS E-243-2000-0-US-01 Gamma-glutamyl Transpeptidase Inhibitors US 60/238,320 Abandoned
NIAID E-208-2000-0-US-01 Ixodes Scapularis Tissue Factor Pathway Inhibitor US 60/240,575 Abandoned
NCI E-290-1997-0-US-06 G-PROTEIN COUPLED RECEPTOR ANTAGONISTS US National Stage 09/601,600 7105488 Abandoned PDF
NCI E-071-1992-1-US-04 Method of Eliminating Inhibitory/Instability Regions of mRNA US CON 09/678,437 6414132 Expired PDF
NCI E-120-2000-0-PCT-02 Chromosome Alterations In Prostate Cancer PCT PCT PCT/US00/027071 Abandoned
NCI E-257-1999-0-PCT-02 CC-Chemokine Receptor 5(CCR5) Gene is Associated With an Increased Risk of Hypertension PCT PCT PCT/US00/41051 Expired
NCI E-257-1999-0-EP-05 CC-CHEMOKINE RECEPTOR 5(CCR5) GENE IS ASSOCIATED WITH AN INCREASED RISK OF HYPERTENSION EP National Stage 00977297.1 Abandoned
NCI E-257-1999-0-AU-03 CC-CHEMOKINE RECEPTOR 5(CCR5) GENE IS ASSOCIATED WITH AN INCREASED RISK OF HYPERTENSION AU National Stage 14952/01 Abandoned
NCI E-257-1999-0-CA-04 METHODS AND COMPOSITIONS FOR CORRELATING CCR5 EXPRESSION WITH ESSENTIAL HYPERTENSION CA National Stage 2387355 Abandoned
NCI E-243-1999-0-AU-04 FIBROBLAST GROWTH FACTOR-5 (FGF-5) IS A TUMOR ASSOCIATED T-CELL ANTIGEN AU National Stage 78371/00 Abandoned
NCI E-010-1999-1-US-02 TREATMENT OF KAPOSI'S SARCOMA WITH IL-12 US DIV 09/672,448 6509321 Abandoned PDF
NCI E-299-1999-0-PCT-02 Cloning and Characterization of ILP2 and ILP3 PCT PCT PCT/US00/26735 Expired
NCI E-243-1999-0-PCT-02 FIBROBLAST GROWTH FACTOR-5 (FGF-5) IS A TUMOR ASSOCIATED T-CELL ANTIGEN PCT PCT PCT/US2000/026689 Expired
NCI E-243-1999-0-JP-06 FIBROBLAST GROWTH FACTOR-5 (FGF-5) IS A TUMOR ASSOCIATED T-CELL ANTIGEN FOR HUMAN RENAL CELL CANCER JP National Stage 2001-528211 Abandoned
NCI E-243-1999-0-EP-03 FIBROBLAST GROWTH FACTOR-5 (FGF-5) IS A TUMOR ASSOCIATED T-CELL ANTIGEN FOR HUMAN RENAL CELL CANCER EP National Stage 00968465.5 Abandoned
NHLBI E-105-2000-0-US-01 Method to Fabricate Continuous Lengths of Helical Coiled Shape Memory Wire US ORD 09/676,157 Abandoned
CIT E-236-2000-0-US-01 System and Method of Creating and Managing Relational Data over a Network US 60/236,508 Abandoned
NCI E-227-2000-0-US-01 HLA-DP Restricted CD4+ T Cell Epitopes From The Cancer Antigen, NY ESO-1 US 60/237,107 Abandoned
NCI E-243-1999-0-CA-05 FIBROBLAST GROWTH FACTOR-5 (FGF-5) IS A TUMOR ASSOCIATED T-CELL ANTIGEN CA National Stage 2384696 Abandoned
NCI E-011-1998-0-US-03 Mammalian Selenoprotein Differentially Expressed in Tumor Cells US CON 09/676,718 6849417 Abandoned PDF
NIDDK E-189-2001-0-PCT-02 USE OF PENTAGASTRIN TO INHIBIT GASTRIC ACID SECRETION OR AS A DIURETIC PCT PCT PCT/US00/26992 Expired
NIAID E-207-2000-0-PCT-01 Ixodes Salivary Anticomplement Protein PCT PCT PCT/US00/26746 Expired
NIDDK E-189-2001-0-US-03 USE OF PENTAGASTRIN TO INHIBIT GASTRIC ACID SECRETION OR AS A DIURETIC US National Stage 09/671,764 7365047 Expired PDF
NCI E-021-1998-0-US-07 Antibodies, Including Fv Molecules, and Immunoconjugates Having High Binding Affinity for Mesothelin and Methods for Their Use US National Stage 09/581,345 6809184 Expired PDF
NCI E-148-2007-2-US-11 Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses US CON 09/670,105 7022814 Expired PDF
NCI E-295-1999-0-US-01 Gene Involved In Dietary Sterol Absorption And Excretion And Uses Therefor US 60/235,268 Abandoned
NIAID E-093-1999-0-CA-09 Mutations Responsible for Attenuation in Measles Virus or Human Respiratory Syncytial Virus Subgroup B CA National Stage 2323927 Abandoned
NIDDK E-185-2000-0-US-01 Identification of The Dombrock Blood Group Glycoprotein As A Polymorphic Member of The ADP-Ribosyltransferase Gene Family US 60/235,162 Abandoned
NIAID E-293-1999-0-CA-04 Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors CA National Stage 2385122 Abandoned
NIAID E-293-1999-0-CY-09 Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors CY EP 00989184.7 Abandoned
NIAID E-293-1999-0-DK-10 Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors DK EP 00989184.7 Abandoned
NIAID E-293-1999-0-BE-08 Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors BE EP 00989184.7 Abandoned
NIAID E-293-1999-0-AT-07 Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors AT EP 00989184.7 Abandoned
NIAID E-293-1999-0-FR-12 Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors FR EP 00989184.7 Abandoned
NIAID E-293-1999-0-DE-13 Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors DE EP 00989184.7 Abandoned
NIAID E-293-1999-0-FI-11 Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors FI EP 00989184.7 Abandoned